发明名称 Verfahren zur Herstellung 6-substituierter 4, 6-Pregnadienderivate
摘要 The invention comprises steroids of the formula <FORM:1021198/C2/1> (wherein Ac is acyl of 1 to 6 carbon atoms; R is H2, H(BCH3) H(a CH3) or = CH2; R1 and R2 are H or together form a methylene group; R3 is b OH, b O acyl, a O alkyl or b O alkyl, the acyl and alkyl groups having 1 to 6 carbon atoms; and X is chlorine, fluorine or methyl; provided that X is not methyl when R, R1 and R2 are hydrogen and R3 is b OH or b O acyl); the preparation of the steroids wherein R3 is b -OH by reduction of the corresponding ketones with a complex metal hydride, or by hydrolysis of functionally modified 3b -ols; and the preparation of the 3-esters or 3-ethers by acylation or alkylation of the 3b -ols. Etherification may, inter alia, be effected via readily hydrolysable esters, such as tosylates or mesylates, which are then reacted with an alcohol, during which either 3a - or 3b -ethers are produced. Examples are given. 3-Ketones used as starting materials can be prepared by 6-dehydrogenation of 3-keto-4-enes. 16-Methyl derivatives are prepared by hydrogenation of the 16-methylene compounds. 1a ,2a - methylene compounds are prepared by addition of diazomethane to 1-dehydro derivatives followed by fusion of the pyrazoline derivative obtained. 6-Chloro compounds are prepared by reacting 3-enol ethers with N-chloro-succinimide followed by 6-dehydrogenation. 17-Acylates are prepared by standard procedures and, if necessary, can be converted to 17a -ols.ALSO:Pharmaceutical compositions, which are ovulation-inhibitors, comprise steroids of the formula <FORM:1021198/A5-A6/1> (wherein Ac is acyl of 1 to 6 carbon atoms; R is H2, H(b CH3), H(a CH3) or =CH2;R1 and R2 are H or together form a methylene group; R3 is b OH, b Oacyl, a Oalkyl or b Oalkyl, the alkyl and aryl groups having 1 to 6 carbon atoms; and X is chlorine, fluorine, or methyl; provided that X is not methyl when R, R1 and R2 are hydrogen and R3 is b OH or b Oacyl), and, if desired, oestrogenic steroids such as ethynyloestradiol or its 3-methyl ether or oestradiol esters, e.g. the 3-acetate, in association with suitable carriers. The steroids also have progesterone activity. Solutions, suspensions, emulsions tablets and pills, which may contain preserving, stabilizing or wetting agents, are referred to.
申请公布号 DE1222922(B) 申请公布日期 1966.08.18
申请号 DE1963M056598 申请日期 1963.04.25
申请人 E. MERCK AKTIENGESELLSCHAFT 发明人 BRUECKNER DIPL.-CHEM. DR. KLAUS;BORK DIPL.-CHEM. DR. KARL-HEINZ;KRAFT DR. HANS GUENTHER;KIESER DR. HARTMUT
分类号 A61K31/56;C07J5/00;C07J7/00;C07J75/00 主分类号 A61K31/56
代理机构 代理人
主权项
地址